Covered recipient · General Payments record
PAMELA K SNYDER
Allopathic & Osteopathic Physicians Obstetrics & Gynecology
General Payments · PY2018–2024
$2,505.47
- Reported across 141 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $286.49 | 15 |
| Education | $94.00 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Astellas Pharma US Inc | $164.32 | 4 |
| ABBVIE INC. | $79.47 | 5 |
| Hologic Sales and Service, LLC | $32.52 | 1 |
| Northgate Technologies, Inc. | $19.86 | 1 |
| Novo Nordisk AS | $18.05 | 1 |
| Meditrina | $17.42 | 1 |
| Bausch Health US, LLC | $16.57 | 1 |
| Organon LLC | $16.47 | 1 |
| PFIZER INC. | $15.81 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $14.65 | 01/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106131276 | CMS |
| ABBVIE INC. | $18.53 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106131278 | CMS |
| ABBVIE INC. | $13.09 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106131280 | CMS |
| ABBVIE INC. | $15.09 | 06/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106131282 | CMS |
| ABBVIE INC. | $18.11 | 11/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106131284 | CMS |
| Astellas Pharma US Inc | $94.00 | 03/05/2024 | Education | Undisputed | 01/23/2026 | 1139345468 | CMS |
| Astellas Pharma US Inc | $26.36 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139335648 | CMS |
| Astellas Pharma US Inc | $19.93 | 08/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139267190 | CMS |
| Astellas Pharma US Inc | $24.03 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139390450 | CMS |
| Bausch Health US, LLC | $16.57 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148022937 | CMS |
| Hologic Sales and Service, LLC | $32.52 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1084874158 | CMS |
| Meditrina | $17.42 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154266308 | CMS |
| Northgate Technologies, Inc. | $19.86 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1079859865 | CMS |
| Novo Nordisk Inc | $18.05 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096876497 | CMS |
| Organon Llc | $16.47 | 04/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136280656 | CMS |
| PFIZER INC. | $15.81 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131266068 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.